Valuation: Abbott Laboratories

Market Cap 19TCr 16TCr 15TCr 14TCr 26TCr 17,75500Cr 26TCr 1,76800Cr 69TCr 8,89900Cr 70TCr 69TCr 29,42000Cr P/E 2026 *
30.9x
P/E 2027 * 23.8x
Enterprise Value 21TCr 18TCr 17TCr 16TCr 29TCr 20,05400Cr 30TCr 1,99700Cr 78TCr 10,05200Cr 79TCr 77TCr 33,23100Cr EV / Sales 2026 *
4.19x
EV / Sales 2027 * 3.81x
Free-Float
86.16%
Yield 2026 *
2.38%
Yield 2027 * 2.52%
1 day+0.58%
1 week+1.76%
Current month+1.76%
1 month+11.61%
3 months+29.10%
6 months+1.76%
Current year-12.63%
1 week 84.5
Extreme 84.5
86.5
1 month 73
Extreme 73
88
Current year 65
Extreme 65
100
1 year 65
Extreme 65
102
3 years 65
Extreme 65
106
5 years 65
Extreme 65
128
10 years 34.75
Extreme 34.75
128
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%+1.76% - - 19TCr
+0.63%+1.09%-17.56%+3.39% 19TCr
+1.12%+1.47%-5.16%+5.81% 11TCr
+0.49%+4.80%+11.17%+72.79% 6.12TCr
+2.38%+3.92%+32.78%+60.21% 5.44TCr
+0.31%+4.19%-7.87%-36.03% 4.82TCr
+2.19%-1.10%+10.92%-23.77% 3.2TCr
-2.99%-15.75% - - 3.09TCr
+0.70%+2.42%+48.28%-10.96% 2.49TCr
-0.63%+1.38%-2.39%+3.80% 2.32TCr
Average +0.41%+1.86%+8.77%+9.40% 6.36TCr
Weighted average by Cap. +0.62%+2.17%-0.50%+11.67%

Financials

2026 *2027 *
Net sales 5.03TCr 4.35TCr 4.06TCr 3.73TCr 7.01TCr 4,78800Cr 7.12TCr 48TCr 19TCr 2,40000Cr 19TCr 18TCr 7,93300Cr 5.46TCr 4.73TCr 4.41TCr 4.05TCr 7.62TCr 5,20100Cr 7.74TCr 52TCr 20TCr 2,60700Cr 21TCr 20TCr 8,61800Cr
Net income 623.06Cr 538.95Cr 503.29Cr 461.7Cr 868.39Cr 59TCr 882.19Cr 5.9TCr 2.32TCr 30TCr 2.34TCr 2.29TCr 98TCr 793.47Cr 686.36Cr 640.95Cr 587.98Cr 1.11TCr 76TCr 1.12TCr 7.52TCr 2.95TCr 38TCr 2.98TCr 2.91TCr 1,25100Cr
Net Debt 2.42TCr 2.09TCr 1.95TCr 1.79TCr 3.37TCr 2,30000Cr 3.42TCr 23TCr 8.99TCr 1,15300Cr 9.07TCr 8.88TCr 3,81100Cr 2.14TCr 1.85TCr 1.73TCr 1.59TCr 2.98TCr 2,03800Cr 3.03TCr 20TCr 7.97TCr 1,02200Cr 8.04TCr 7.87TCr 3,37700Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change
07/26/07 CHF 86.50 +0.58%
06/26/06 CHF 86.00 +1.78%
05/26/05 CHF 84.50 -1.74%
04/26/04 CHF 86.00 -0.58%
03/26/03 CHF 86.50 +1.76%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
107.81USD
Average target price
118.42USD
Spread / Average Target
+9.84%

Quarterly revenue - Rate of surprise